• Employees
  • Careers
  • Investors
  • News
  • Partners
  • Contact Us
Find
  • Our Company
  • Our Caring
  • Our Products
  • Home
  • Investor Relations
    • Annual Reports & Proxy
    • Awards & Recognition
    • Company Information
    • Corporate Governance
    • Financial Information
    • News Releases
    • Pharmaceutical Pipeline
    • SEC Filings
    • Shareholder Services
    • Stock Information
    • Webcasts & Presentations
    • Investor Tools
    • Investor Contacts
Investor Relations  >  Corporate Governance  >  Compensation & Benefits Committee Charter
  • Text Size
  • Text Only
  • Email to a Friend
  • Printer Friendly
  • RSS

Compensation & Benefits Committee Charter

Committee's Purpose
The Compensation & Benefits Committee (the "Committee) is appointed by the Board of Directors ("Board") to discharge the Board's duties and responsibilities relating to compensation of the Company's directors and executive officers and oversight of the management of the various pension, long-term incentive, savings, health and welfare plans that cover the Company's employees.
Committee Membership
The Committee shall be composed entirely of not less than three non-employee, independent members of the Board of Directors. All members of the Committee shall meet the "independence" requirements of the New York Stock Exchange and any applicable laws, rules and regulations.

The Board, by resolution of a majority of the non-employee directors, shall appoint (and may remove) the members of the Committee. Each member of the Committee shall be literate in compensation and benefit-related matters. Such literacy shall be determined by the Board in its business judgment.
Committee Chairman
The Board, by resolution of a majority of the non-employee directors, shall designate one member of the Committee to act as the Chairman of the Committee. The Committee member so designated shall (a) chair all meetings of the Committee; (b) coordinate the evaluation of the performance of the Chief Executive Officer ("CEO"); and (c) perform such other activities as from time to time are requested by the other directors or as circumstances indicate.
Committee's Duties and Responsibilities
1. The Committee shall review and discuss the "Compensation Discussion and Analysis" section of the Company's proxy statement with management.

2. The Committee shall produce an annual report stating it has reviewed and discussed the "Compensation Discussion and Analysis" section of the Company's proxy statement with management.

3. The Committee shall assess the Company's financial and non-financial goals versus actual performance, including against the background of the factors and principles outlined in the Credo, evaluate the CEO in light of this performance, and set the CEO's compensation level based on this evaluation.

4. The Committee shall review and provide oversight of the Company's compensation philosophy and composition of the peer company community used for market comparison, and shall approve the establishment of competitive targets versus the peer community and all equity-based plans requiring shareholder approval.

5. The Committee shall review eligibility criteria and award guidelines for corporate-wide compensation programs in which management level employees participate, including all forms of long-term incentive compensation.

6. The Committee shall review the design and management of the various pension, savings, health and welfare plans that cover the employees of Johnson & Johnson companies.

7. The Committee shall review the funded status and investment performance of the benefit plan trusts in which benefit assets are invested.

8. The Committee shall conduct an annual evaluation of its performance in fulfilling its duties and responsibilities under this Charter.

9. The Committee shall meet at least four times per year and at such times and places and by such means as the Chairman shall determine. The Committee shall make regular reports to the Board.

10. The Committee shall review and approve any recommended compensation actions for the Company's Executive Committee members, including base salary, annual incentive bonus, long-term incentive awards, severance benefits, and perquisites.

11. The Committee may form and delegate authority to subcommittees when appropriate.

12. The Committee has delegated to the Company's Management Compensation Committee, comprised of members of the Executive Committee, the responsibility for the review and approval of the compensation of non-Executive Committee officers and other key executives of the Company.

13. The Committee shall review verification from the Company's independent auditors that compensation awards to members of the Executive Committee, including the CEO, comply with all requirements of the Company's Executive Incentive Plan.

14. The Committee shall determine and/or approve awards to employees of long-term incentives pursuant to any of the Company's employee Long-Term Incentive Plans and to exercise such other power and authority as may be permitted or required under such Long-Term Incentive Plans, and shall monitor aggregate equity compensation share use, dilution and expense. At the Committee's discretion, the approval of long-term incentives to employees, other than to members of the Executive Committee, may be delegated to the Management Compensation Committee.

15. The Committee shall from time to time review and approve compensation (fees and equity) for the non-employee directors.

16. The Committee shall have the responsibility to comply with applicable requirements as established by the Securities and Exchange Commission, New York Stock Exchange or other governing regulatory authority regarding compensation consultants used to assist in the evaluation of the CEO, other executive officers or non-employee members of the Board.

17. The Committee shall have the authority and appropriate funds to obtain advice and assistance from internal or external legal, accounting or other advisors. The Committee shall have authority to retain and terminate any compensation consultant retained to assist in the evaluation of director, CEO or senior executive compensation, including the authority to approve fees and other retention terms.

18. The Committee shall, on an annual basis, review and reassess the adequacy of this Charter and recommend any proposed changes to the Board for approval.

Committee Members

Chair Arnold G. Langbo
Committee Member Michael M.E. Johns, M.D.
Committee Member William D. Perez
Committee Member Charles Prince

Add to Briefcase Add to Briefcase

PDF Download PDF 8.6 KB

  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
This site is governed solely by applicable U.S laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy.Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson.Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc. 1997-2009. All Rights Reserved.
  • Employees
  • Careers
  • Investors
  • News
  • Partners
  • Contact Us
Johnson & Johnson
  • Home
  • Our Products
  • Our Caring
  • Our Company
  • Text Size
  • Graphic Version
  • Email to a Friend
  • Printer Friendly
  • RSS

Our Management Approach

  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
This site is governed solely by applicable U.S laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy.Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson.Contact Us with any questions or search this site for more information.
All contents © Johnson & Johnson Services, Inc. 1997-2009. All Rights Reserved.